MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 42 filers reported holding MILLENDO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 715,201 | $4,820,000 | 2.31% |
| FRAZIER MANAGEMENT LLC | 1,396,615 | $9,413,000 | 1.58% |
| GREAT POINT PARTNERS LLC | 1,729,759 | $11,659,000 | 1.02% |
| Monashee Investment Management LLC | 140,168 | $945,000 | 0.88% |
| Bpifrance SA | 1,078,670 | $7,270,000 | 0.84% |
| AWM Investment Company, Inc. | 611,900 | $4,124,000 | 0.81% |
| NEA Management Company, LLC | 1,766,779 | $11,908,000 | 0.56% |
| ADAMS STREET PARTNERS LLC | 312,279 | $2,105,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,825 | $1,191,000 | 0.43% |
| DAFNA Capital Management LLC | 129,525 | $873,000 | 0.30% |